Executive Summary
High-value federal contracts totaling $3.37B signal robust demand for IT services, construction, and biotech R&D, with 19 bullish awards dominated by GSA/DHS/DoD spending providing multi-year revenue visibility through 2049. Public firms like Booz Allen Hamilton, Lockheed Martin, SAIC, and Textron capture significant shares amid unexercised options exceeding $2B across portfolio. Investors should prioritize IT/defense contractors for steady backlog growth, while monitoring firm-fixed-price exposure in construction and low initial outlays signaling execution risks.
Tracking the trend? Catch up on the prior High-Value Federal Grants ($5M+) digest from February 19, 2026.
Investment Signals(4)
- GSA IT Services Boom(HIGH)▲
Multiple GSA awards >$100M each to Booz Allen, Tatitlek, Manta, SAIC, Amentum highlight $500M+ in obligated IT/engineering support with options doubling values.
- Defense Construction Commitments(HIGH)▲
Clark and Kiewit secure $857M combined for hospital and disaster recovery builds, extending to 2028 with full obligations signaling infra spend.
- Long-Term Space R&D Lock-In(MEDIUM)▲
Lockheed Martin awarded $371M potential through 2049 for NASA GEOXO instrument, with $74M obligated.
- BARDA Biotech Funding Surge(HIGH)▲
$365M+ to Paratek and Luminary for biothreat antibiotics/R&D through 2029, with $128M+ outlayed indicating execution.
Risk Flags(3)
- Execution[HIGH RISK]▼
Firm-fixed-price structures across 12 contracts expose contractors to cost overruns in construction (Clark, Kiewit) and R&D (Paratek, Luminary), amplified by low outlays in 10 awards.
- Execution[MEDIUM RISK]▼
Zero outlays in 8 contracts totaling $600M+ (e.g., Tatitlek, SAIC, Amentum) signal potential funding delays or non-starts.
- Market[MEDIUM RISK]▼
Heavy subawarding (e.g., Peraton $258M subs, Amentum 70 subs) risks margin erosion and dependency.
Opportunities(3)
- ◆
Unexercised options >$2B across awards (e.g., SAIC $268M, Peraton $142M, Lockheed $297M) could double obligated values.
- ◆
Extensions to 2028-2049 in 10 contracts (e.g., Textron to 2031, Saab to 2039) position for backlog compounding.
- ◆
Disaster recovery (Kiewit $241M Helene) and repeat suppliers (Perimeter fire retardant) signal follow-on potential.
Sector Themes(3)
- ◆
13/21 awards ($1.6B+ obligated) in NAICS 541512/541330 to GSA/DHS/DoD for IT/engineering, with options tripling values.
- ◆
$858M in DoD/USDA builds/recovery (hospitals, bridges) via design-build FFP to 2028.
- ◆
HHS/BARDA $365M+ for antibiotics/biotech to 2029, favoring small biz innovators.
Watch List(3)
- 👁
{"entity"=>"SAIC", "reason"=>"$327M potential PBGC IT support to 2033 with $59M obligated but $0 outlayed.", "trigger"=>"outlay ramp or option exercise >$100M"}
- 👁
{"entity"=>"Lockheed Martin", "reason"=>"NASA $371M GEOXO to 2049 offers decade-long space revenue amid options.", "trigger"=>"additional NASA R&D awards or FY2027 obligation increase"}
- Dual $818M GSA/VA IT wins with expiring periods.👁
{"title"=>"Dual $818M GSA/VA IT wins with expiring periods.", "entity"=>"Booz Allen Hamilton", "reason"=>"GSA transfer and VA CCP signal GSA expansion.", "trigger"=>"follow-on task orders post-2024/2026"}
Get daily alerts with 4 investment signals, 3 risk alerts, 3 opportunities and full AI analysis of all 21 filings
🇺🇸 More from United States
View all →March 25, 2026
US Pre-Market SEC Filings Roundup — March 25, 2026
US Pre-Market SEC Filings Roundup
March 24, 2026
US Merger & Acquisition SEC Filings — March 24, 2026
US Merger & Acquisition SEC Filings
March 24, 2026
US Corporate Board Director Changes SEC Filings — March 24, 2026
US Corporate Board Director Changes SEC Filings
March 24, 2026
US Executive Officer Management Changes SEC — March 24, 2026
US Executive Officer Management Changes SEC